Address And Details

333 S Hope St , Los Angeles, CA 90071
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

Depending on the proximity to its target date, which we define as the year that corresponds roughly to the year in which the investor expects to retire, the fund will seek to achieve the following objectives to varying degrees: growth, income and conservation of capital. The fund will increasingly emphasize income and conservation of capital by investing a greater portion of its assets in fixed income, equity-income and balanced funds as it approaches and passes its target date. In this way, the fund seeks to balance total return and stability over time. The fund will attempt to achieve its investment objectives by investing in a mix of American Funds in different combinations and weightings. The underlying American Funds represent a variety of fund categories, including growth funds, growth-and-income funds, equity-income funds, balanced funds and fixed income funds. The fund categories represent differing investment objectives. For example, growth funds seek long-term growth primarily through investing in both U.S. stocks and stocks of issuers domiciled outside the U.S. Growth-and-income funds seek long-term growth and income primarily through investments in stocks. Equity-income and balanced funds generally strive for income and growth through stocks and/or fixed income investments, while fixed income funds seek current income through investments in bonds or in other fixed income instruments. The fund is designed for investors who plan to retire in, or close to, the fund s target date that is, the year designated in the fund s name. However, investors may purchase shares of the fund throughout the life of the fund, including after the target date. In an effort to achieve the fund s overall investment objective, the fund will continue to provide equity exposure after the target date has passed. The fund s investment adviser periodically reviews the investment strategies and asset mix of the underlying funds and may, from time to time, rebalance or modify the asset mix of the funds and change the underlying fund investments. The investment adviser may also determine not to change the underlying fund allocations, particularly in response to short-term market movements, if in its opinion the combination of underlying funds is appropriate to meet the fund s investment objective. According to its current investment approach, the investment adviser will continue to manage the fund for approximately thirty years after the fund reaches its target date. As reflected in the glide path below, the fund s asset allocations will change throughout this period. Thirty years after its target date, the fund may be combined with other funds in a single portfolio with an investment allocation that will not evolve beyond that which is in effect at that time. The following glide path chart illustrates the investment approach of the fund by showing how its investment in the various fund categories will change over time. The glide path represents the shifting of asset classes over time and shows how the fund s asset mix becomes relatively more conservative both prior to and after retirement as time elapses. Although the glide path is meant to dampen the fund s potential volatility as retirement approaches, the fund is not designed for a lump sum redemption at the retirement date. The fund s asset allocation strategy promotes asset accumulation prior to retirement, but it is also intended to provide equity exposure throughout retirement to deliver capital growth potential. The fund will seek dividend income to help dampen risk while maintaining equity exposure, and will invest in fixed income securities to help provide current income, capital preservation and inflation protection. The allocations shown reflect the target allocations as of January 1, 2020.

Net Asset Value

as of 5:23 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.37%
  • 1 Month
  • +1.35%
  • 3 Months
  • +3.61%
  • 1 Yr Return
  • +24.77%
  • 5 Yr Return
  • +68.54%

Equity Sector Breakdown

Finance 100.02%
ConsumerDurables n/a
Energy n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 100.02%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Stocks -0.02%
Total Net Assets 260.00 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -0.12 -0.40 -0.94
Beta 0.84 0.83 0.85
R Squared 0.97 0.95 0.95
Std Deviation 15.86 12.79 11.73
Sharpe Ratio 0.98 1.12 n/a

Purchase Information

as of 5:29 PM ET 09/16/2021
Minimum Initial $250
Minimum Additional $50
Minimum Initial IRA $25

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +27.13%
  • +35.03%
+27.13% +35.03%
3 Year
  • +15.30%
  • +15.13%
+15.30% +15.13%
10 Year
  • +13.03%
  • +11.82%
+13.03% +11.82%
Life Of Fund
  • +12.36%
  • +12.22%
+12.36% +12.22%

Top 10 Holdings

Symbol Company Name % Of Assets
CWICX AMERICAN FD CAP WRLD GR & INC 9.93%
SMCWX AMERICAN SMALLCAP WLD FUND 9.70%
ANWPX NEW PERSPECTIVE FUND INC 9.70%
ANCFX FUNDAMENTAL INVESTORS INC 9.00%
AWSHX AMERICAN WA MUTUAL INVD CLS A 8.05%
AIVSX THE INVEST COMPANY OF AMERICA 7.73%
AGTHX AMERICAN GROWTH FUND OF AMER 7.00%
AMCPX AMERICAN FUNDS AMCAP 7.00%
AMRMX AMERICAN MUTUAL FUND INC 5.33%
AMUSX US GOVERNMENT SECURITIES FD 5.02%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.